SCHEMBL30903283

CC[C@H](C)[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O

nearest known ligand 0.68

Predicted protein targets (top 12)

	gene	UniProt	supporting neighbours	confidence
▸	C5AR1	P21730	2/20	0.68

▸	NPY1R	P25929	1/20	0.62

▸	NPY2R	P49146	1/20	0.62

▸	NPY4R	P50391	1/20	0.62

▸	NPY5R	Q15761	1/20	0.62

▸	GLP1R	P43220	6/20	0.60

▸	KISS1R	Q969F8	4/20	0.60

▸	F2	P00734	4/20	0.59

▸	CCKBR	P32239	2/20	0.58

▸	GCGR	P47871	3/20	0.58

▸	CXCR4	P61073	1/20	0.57

▸	EED	O75530	1/20	0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL29637829	0.95	C5AR1 (0.68)	C5AR1NPY1RNPY2RNPY4RNPY5R
SCHEMBL30495687	0.92	NPY1R (0.68)	C5AR1NPY1RNPY2RNPY4RNPY5R
SCHEMBL29965312	0.91	NPY1R (0.68)	C5AR1NPY1RNPY2RNPY4RNPY5R
SCHEMBL29429574	0.90	GLP1R (0.69)	C5AR1NPY1RNPY2RNPY4RNPY5R
SCHEMBL30392169	0.90	C5AR1 (0.66)	C5AR1NPY1RNPY2RNPY4RNPY5R
SCHEMBL30903284	0.90	MAPK8 (0.60)	C5AR1NPY1RNPY2RNPY4RNPY5R
SCHEMBL30392901	0.89	C5AR1 (0.65)	C5AR1NPY1RNPY2RNPY4RNPY5R
SCHEMBL31402803	0.89	GLP1R (0.69)	C5AR1NPY1RNPY2RNPY4RNPY5R
SCHEMBL31182592	0.89	C5AR1 (0.68)	C5AR1NPY1RNPY2RNPY4RNPY5R
SCHEMBL30859276	0.89	NPY1R (0.65)	C5AR1NPY1RNPY2RNPY4RNPY5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20240148849-A1	IMMUNOGENIC COMPOSITION, USE AND METHODS	GLAXOSMITHKLINE BIOLOGICALS SA (BE)	2024-05-09	—	—	US	disclosed